Montevarchi

Researchers are evaluating a program called EuroHeart, developed by the European Society of Cardiology (ESC), which aims to improve care for patients with common heart conditions like Acute Coronary Syndrome (ACS), heart failure, and atrial fibrillation. This observational, prospective, multicenter initiative collects standardized patient data continuously in real-world clinical settings to support ongoing quality improvement. The focus is on how well healthcare providers follow ESC quality indicators proven to improve patient outcomes, addressing gaps between research and everyday practice. The study specifically looks at the Italian implementation of EuroHeart, monitoring adherence to ESC quality indicators in clinical care. It does not involve experimental treatments but collects detailed data on the management of patients hospitalized with ACS, heart failure, or atrial fibrillation. Participants' care is tracked throughout their hospital stay and beyond, with no additional interventions imposed by the study. Participants will be followed for 12 months after enrollment. During this period, researchers will collect data on clinical events, treatment adherence, and patient status to evaluate how well ESC quality indicators are met, such as timely reperfusion for STEMI patients and appropriate medication prescriptions at discharge. This long-term follow-up supports efforts to enhance care quality and patient outcomes in cardiovascular diseases.

Researchers are evaluating Tensi+, a newly released medical device that uses transcutaneous-posterior tibial nerve stimulation (TC-pTNS) to manage overactive bladder (OAB). This registry study aims to gather data from a large number of patients over one year to assess the device's effectiveness, safety, and factors that may predict successful treatment in real-world clinical settings. Participants in this study will use the Tensi+ device designed to stimulate the posterior tibial nerve through the skin. The study does not mention different groups or comparator treatments, focusing instead on collecting observational data during routine clinical care over a 12-month period. Throughout the study, participants will be monitored to assess subjective improvement at 3 and 12 months. Researchers will collect safety information and evaluate how well patients respond to the device over time. Patient involvement includes maintaining voiding diaries and attending follow-up assessments as part of the year-long observation.